James Howard, MD: UCB’s Global Corporate Website press released regarding the RAISE clinical trial of zilucoplan
April 14, 2023
On April 13th, 2023, the UCB’s Global Corporate Website released a press statement regarding the RAISE clinical trial of zilucoplan – one of two drugs being reviewed for the treatment of myasthenia gravis. The trial was led by James Howard, MD, who is a neurology professor at the ´óÏó´«Ã½ School...